查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600753

藥物釋放型球市場：按類型、塗層技術和最終用戶分類 - 2025-2030 年全球預測

Drug Eluting Balloon Market by Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon), Coating Technology (EnduraCoat, FreePac, Paccocath), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年藥物釋放型球囊市值為9,6584萬美元，預計2024年將達到109831萬美元，複合年成長率為15.51%，預計2030年將達到265047萬美元。

藥物釋放型球囊（DEB）是主要用於介入心臟病學領域的醫療設備。 DEB 將傳統血管成形術用氣球的機械特性與藥物釋放型的製藥優勢相結合，描述了一種治療血管疾病的創新解決方案。 DEB 市場受到心血管疾病盛行率上升、微創手術意識不斷增強以及醫療設備技術進步的推動。在冠狀動脈疾病和周邊動脈疾病的治療中，透過直接向受影響區域施用抗增殖藥物來解決再血管再阻塞。最終用途包括醫院、門診手術中心和專科診所，這大大推動了 DEB 的需求。

主要市場統計
基準年[2023] 9.6584億美元
預測年份 [2024] 1,098,310,000 美元
預測年份 [2030] 26.5047億美元
複合年成長率（%） 15.51%

由於世界老化和慢性病的增加，該市場顯示出廣泛的成長潛力。專注於改進藥物配方和易於使用的輸送機制的創新產品設計可以幫助您利用潛在的商機。透過進入醫療基礎設施逐漸改善的新興市場，可以進一步擴大市場。然而，嚴格的監管條件以及高昂的程序和產品開發成本是主要限制因素。成長也受到球囊滑移和藥物輸送不一致等技術挑戰的阻礙。

創新應致力於提高藥物釋放的有效性並擴大可透過 DEB 輸送的藥物範圍。開發解決方案來克服技術障礙並提高製造成本效益是一個及時的研究領域。設備製造商和製藥公司之間的合作可以加速新產品的開發。市場仍然充滿活力，強大的競爭環境推動著持續的成長和適應。透過有針對性的研究和策略聯盟來應對這些挑戰，相關人員可以顯著影響 DEB 市場的發展軌跡。

市場動態：揭示快速發展的藥物釋放型球囊市場的關鍵市場洞察

供需的動態交互作用正在改變藥物釋放型球囊市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 老年人增加導致心血管疾病
    • 周邊動脈疾病和冠狀動脈疾病的盛行率上升
    • 有利的核准支持 DEB 的發展
  • 市場限制因素
    • 藥物釋放型球囊召回問題
  • 市場機會
    • 藥物塗層球囊導管臨床應用新進展
    • 藥物塗層球囊的進展、創新與研究
  • 市場問題
    • 缺乏熟練的專業人員

波特五力：駕馭藥物釋放型球囊市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解藥物釋放型球市場的外部影響

外部宏觀環境因素在塑造藥物釋放型球市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解藥物釋放型球囊市場的競爭格局

藥物釋放型球市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：藥物釋放型球囊市場供應商的績效評估

FPNV定位矩陣是評估藥物釋放型球囊市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵焦點細分市場的全面市場分析。

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 老年人口數量增加導致心血管疾病
      • 周邊動脈疾病和冠狀動脈疾病的盛行率增加
      • 良好的核准支持 DEB 的發展
    • 抑制因素
      • 與藥物釋放型球囊產品召回相關的問題
    • 機會
      • 藥物塗層球囊導管臨床應用新進展
      • 藥物塗層球囊的進展、創新與研究
    • 任務
      • 缺乏熟練且訓練有素的專業人員
  • 市場區隔分析
    • 類型：冠狀動脈 DEB 在改善遞送和藥物遷移的重要性
    • 包衣技術：enduraCoat 因其卓越的局部藥物釋放特性而越來越受歡迎
    • 最終用戶：易用性和程序速度提高了導管實驗室 DEB 的採用率
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境
  • 客戶客製化

第6章藥物釋放型球市場：依類型

  • 介紹
  • 冠狀動脈塗藥氣球
  • 周邊設備藥物釋放型球囊

第7章藥物釋放型球市場：塗層技術

  • 介紹
  • EnduraCoat
  • FreePac
  • 帕科卡斯
  • 跨太平洋運輸公司

第8章藥物釋放型球囊市場：依最終用戶分類

  • 介紹
  • 門診手術中心
  • 導管實驗室
  • 醫院

第9章美洲藥物釋放型球市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太藥物釋放型球囊市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲藥物釋放型氣球市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • Advanced NanoTherapies (ANT) 獲得 400 萬美元戰略投資，加速 SirPlux Duo 藥物塗層球囊 (DCB) 的臨床開發，用於治療新型冠狀動脈疾病 (CAD)
    • Translumina 收購 Blue Medical Devices 進一步強化技術組合
    • Surmodics 的 SurVeil 藥物塗層球囊獲得 FDA核准

公司名單

  • Medtronic PLC
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • MA Med Alliance SA by Cordis Corporation
  • Eurocor Tech GmbH
  • Lepu Medical Technology
  • Invamed
  • BIoTronik SE & Co. KG
  • Cook Medical, Inc.
  • Terumo Corporation
  • Cardionovum GmbH
  • SurModics, Inc.
  • Johnson & Johnson Services, Inc.
  • Balton Sp. z oo
  • B. Braun Melsungen AG
  • Bayer AG
  • Abbott Laboratories
  • Wellinq
  • Laborie Medical Technologies, Inc.
  • Concept Medical
  • Zylox-Tonbridge Medical Technology Co., Ltd.
  • Biosensors International Group, Ltd.
  • Koninklijke Philips NV
  • iVascular SLU
Product Code: MRR-4348D129FA8E

The Drug Eluting Balloon Market was valued at USD 965.84 million in 2023, expected to reach USD 1,098.31 million in 2024, and is projected to grow at a CAGR of 15.51%, to USD 2,650.47 million by 2030.

A Drug Eluting Balloon (DEB) is a medical device used primarily in the field of interventional cardiology. It combines the mechanical feature of a traditional angioplasty balloon with the pharmaceutical benefits of drug elution, providing an innovative solution for treating vascular diseases. The DEB market is driven by the rising prevalence of cardiovascular diseases, increasing awareness regarding minimally invasive procedures, and technological advancements in healthcare devices. Crucial to its application are the treatments for coronary artery disease and peripheral artery disease, addressing restenosis by delivering anti-proliferative drugs directly to the affected site. End-use scope includes hospitals, ambulatory surgical centers, and specialized clinics, significantly driving the demand for DEBs.

KEY MARKET STATISTICS
Base Year [2023] USD 965.84 million
Estimated Year [2024] USD 1,098.31 million
Forecast Year [2030] USD 2,650.47 million
CAGR (%) 15.51%

The market shows promising growth potential, fueled by the increasing global aging population and subsequent rise in chronic disease occurrences. Potential opportunities can be harnessed through innovative product designs focusing on improved drug formulations and user-friendly delivery mechanisms. Further market expansion can be achieved by entering emerging markets where healthcare infrastructure is progressively improving. However, stringent regulatory landscapes and high costs of procedure and product development are key limitations. Technical challenges such as balloon slippage and inconsistent drug delivery also hinder growth.

Innovation should be directed towards enhancing the efficacy of drug release and expanding the range of drugs that can be delivered via DEBs. Developing solutions to overcome technical barriers and improving the cost-effectiveness of production are areas ripe for research. Collaborations between device manufacturers and pharmaceutical companies could foster new product developments. The market remains dynamic, with a strong competitive environment encouraging continuous growth and adaptation. By addressing these challenges through targeted research and strategic collaborations, stakeholders can significantly influence the trajectory of the DEB market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Eluting Balloon Market

The Drug Eluting Balloon Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Geriatric Population Leading to Cardiovascular Diseases
    • Rising Prevalence of Peripheral and Coronary Artery Diseases
    • Favorable Approvals to Support the Growth of DEBs
  • Market Restraints
    • Issues Associated to Product Recalls of Drug-Eluting Balloons
  • Market Opportunities
    • New Developments in the Clinical Use of Drug-Coated Balloon Catheters
    • Advancement, Innovation, and Research in Drug-Coated Balloons
  • Market Challenges
    • Lack of Availability for Skilled and Trained Professionals

Porter's Five Forces: A Strategic Tool for Navigating the Drug Eluting Balloon Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Eluting Balloon Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Eluting Balloon Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Eluting Balloon Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Eluting Balloon Market

A detailed market share analysis in the Drug Eluting Balloon Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Eluting Balloon Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Eluting Balloon Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Drug Eluting Balloon Market, highlighting leading vendors and their innovative profiles. These include Medtronic PLC, Becton, Dickinson and Company, Boston Scientific Corporation, M.A. Med Alliance SA by Cordis Corporation, Eurocor Tech GmbH, Lepu Medical Technology, Invamed, Biotronik SE & Co. KG, Cook Medical, Inc., Terumo Corporation, Cardionovum GmbH, SurModics, Inc., Johnson & Johnson Services, Inc., Balton Sp. z o. o., B. Braun Melsungen AG, Bayer AG, Abbott Laboratories, Wellinq, Laborie Medical Technologies, Inc., Concept Medical, Zylox-Tonbridge Medical Technology Co., Ltd., Biosensors International Group, Ltd., Koninklijke Philips N.V., and iVascular S.L.U..

Market Segmentation & Coverage

This research report categorizes the Drug Eluting Balloon Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Coronary Drug Eluting Balloon and Peripheral Drug Eluting Balloon.
  • Based on Coating Technology, market is studied across EnduraCoat, FreePac, Paccocath, and TransPax.
  • Based on End User, market is studied across Ambulatory Surgery Centers, Cath Labs, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Geriatric Population Leading to Cardiovascular Diseases
      • 5.1.1.2. Rising Prevalence of Peripheral and Coronary Artery Diseases
      • 5.1.1.3. Favorable Approvals to Support the Growth of DEBs
    • 5.1.2. Restraints
      • 5.1.2.1. Issues Associated to Product Recalls of Drug-Eluting Balloons
    • 5.1.3. Opportunities
      • 5.1.3.1. New Developments in the Clinical Use of Drug-Coated Balloon Catheters
      • 5.1.3.2. Advancement, Innovation, and Research in Drug-Coated Balloons
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of Availability for Skilled and Trained Professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Significance of coronary DEBs in enhancing deliverability and drug transfer
    • 5.2.2. Coating Technology: Growing preferences for enduraCoat with better local drug release profile
    • 5.2.3. End User: Higher adoption of DEBs in Cath Labs owing to ease of use and speed of the procedure
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Drug Eluting Balloon Market, by Type

  • 6.1. Introduction
  • 6.2. Coronary Drug Eluting Balloon
  • 6.3. Peripheral Drug Eluting Balloon

7. Drug Eluting Balloon Market, by Coating Technology

  • 7.1. Introduction
  • 7.2. EnduraCoat
  • 7.3. FreePac
  • 7.4. Paccocath
  • 7.5. TransPax

8. Drug Eluting Balloon Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Cath Labs
  • 8.4. Hospitals

9. Americas Drug Eluting Balloon Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Eluting Balloon Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Eluting Balloon Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Advanced NanoTherapies (ANT) Secures USD 4 Million Strategic Investment to Accelerate Clinical Development of SirPlux Duo Drug-Coated Balloon (DCB) for Treating de novo Coronary Artery Disease (CAD)
    • 12.3.2. Translumina further Strengthens Its Technology Portfolio with Acquisition of Blue Medical Devices, Netherlands
    • 12.3.3. Surmodics Receives FDA Approval for the SurVeil Drug-Coated Balloon

Companies Mentioned

  • 1. Medtronic PLC
  • 2. Becton, Dickinson and Company
  • 3. Boston Scientific Corporation
  • 4. M.A. Med Alliance SA by Cordis Corporation
  • 5. Eurocor Tech GmbH
  • 6. Lepu Medical Technology
  • 7. Invamed
  • 8. Biotronik SE & Co. KG
  • 9. Cook Medical, Inc.
  • 10. Terumo Corporation
  • 11. Cardionovum GmbH
  • 12. SurModics, Inc.
  • 13. Johnson & Johnson Services, Inc.
  • 14. Balton Sp. z o. o.
  • 15. B. Braun Melsungen AG
  • 16. Bayer AG
  • 17. Abbott Laboratories
  • 18. Wellinq
  • 19. Laborie Medical Technologies, Inc.
  • 20. Concept Medical
  • 21. Zylox-Tonbridge Medical Technology Co., Ltd.
  • 22. Biosensors International Group, Ltd.
  • 23. Koninklijke Philips N.V.
  • 24. iVascular S.L.U.

LIST OF FIGURES

  • FIGURE 1. DRUG ELUTING BALLOON MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG ELUTING BALLOON MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DRUG ELUTING BALLOON MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DRUG ELUTING BALLOON MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG ELUTING BALLOON MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG ELUTING BALLOON MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY CORONARY DRUG ELUTING BALLOON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY PERIPHERAL DRUG ELUTING BALLOON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY ENDURACOAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY FREEPAC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY PACCOCATH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TRANSPAX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY CATH LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. DRUG ELUTING BALLOON MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. DRUG ELUTING BALLOON MARKET, FPNV POSITIONING MATRIX, 2023